Myocardial Infarction in the Young: A Retrospective Clinical Registry Study

Western Sydney Local Health District0 个研究点目标入组 1,000 人开始时间: 2023年10月20日最近更新: 2023年10月30日

适应症

试验速览

暂无简介。

•1. Patients aged =>18 years and <=50 years old with acute myocardial infarction (MI)
•2. Patients aged >50 years and with acute myocardial infarction (MI) (control group)
•2. Type 1 and Type 2 MI are both included, with MI defined according to the 4th universal definition: clinical evidence of acute myocardial ischaemia and detection of a rise and/or fall of cTroponin values with at least 1 value above the 99th percentile upper reference limit and, at least one of the following:
•a. Symptoms of myocardial ischaemia;
•b. New ischaemic ECG changes;
•c. Development of pathological Q waves;
•d. Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality in a pattern consistent with an ischaemic aetiology;
•e. Identification of a coronary thrombus by angiography or autopsy
•3. Participants must have undergone coronary angiography

•# Rise in cardiac biomarkers and/or ECG changes due to a clear non-coronary artery pathology e.g. myocarditis, acute arrhythmia, cardiomyopathy, acute pulmonary embolism (PE), stroke, recent cardiac surgery (these can all cause ischaemic changes on the ECG and/or troponin rises)
•#Patients with presumed MI who die before the diagnosis has been confirmed by troponin values or coronary angiography (Type 3 MI)
•#Percutaneous coronary intervention (PCI)-related MI (Type 4 MI)
•#Coronary artery bypass grafting (CABG)-related MI (Type 5 MI)

发起方